Dr. Lalchandani Labs Ltd.BSE: DLCL

Closure of Trading Window

· Issued by Dr. Lalchandani Labs Ltd. via BSE India

Filed with BSE · · 1 page · English

Summary by 6ix AI

Dr. Lalchandani Labs Ltd. has announced the closure of its trading window for certain individuals in compliance with insider trading regulations. The date for the board meeting to discuss these financial results will be communicated later.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Subject: Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulation, 2015 In compliance with the BSE Circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019; regarding trading restriction period, provisions of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Compa

Dr. Lalchandani Labs Ltd. on 6ix

Earlier from Dr. Lalchandani Labs

All Dr. Lalchandani Labs news releases